Inovio Pharmaceuticals Inc

INO

Market Cap$261.28M

Close$

Compare Inovio Pharmaceuticals

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Inovio Pharmaceuticals Inc	-1.9	0%	-115%	-	0.1
Market Avg	54.3	1.27%	32%	-	1.3
Industrials Avg	20.1	0.95%	19%	3.1	0.6

$4.00

Target Price by Analysts

69.4% downsideInovio Pharmaceuticals Target Price Details

$-1.44

Current Fair Value

111% downside

Overvalued by 111% based on the discounted cash flow analysis.

Share Statistics

Market cap	$261.28 Million
Enterprise Value	$132.76 Million
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$-6.09
Beta	1.53
Outstanding Shares	23,370,365
Avg 30 Day Volume	310,649

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	-1.93
PEG	3.57
Price to Sales	-
Price to Book Ratio	2.61
Enterprise Value to Revenue	159.56
Enterprise Value to EBIT	-1
Enterprise Value to Net Income	-1
Total Debt to Enterprise	0.13
Debt to Equity	0.14

Revenue Sources

No data

ESG Score

No data

About Inovio Pharmaceuticals Inc

CEO: Jong Kim